Professor Tom Foltynie is Professor of Neurology at University College London and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery.

He has a specialist interest in Parkinson’s disease (PD), Deep Brain stimulation and the development of novel treatments for PD.

Prof. Foltynie is involved in several trials of new treatments for PD, including chief investigator for a series of trials of Exenatide- a potential neurorestorative treatment for PD.

He is excited to be continuing his work in exploring disease modifying treatments for PD through EJS ACT-PD.

Camille Carroll is a Professor of Clinical Neuroscience at Newcastle University.  Her research is focused on disease modification and the use of digital health technologies for monitoring and personalised care in Parkinson’s.

Prof. Carroll has led the development of a national web-based research registry for Parkinson’s disease. She co-chairs the international Linked Clinical Trials Committee, prioritising repurposed drugs for disease modification trials in Parkinson’s. She is the joint clinical director of the Parkinson’s Excellence Network in the UK. Additionally, she is co-chair of the international Movement Disorders Society Patient and Carer Committee, deputy chair of the Parkinson's Disease Clinical Studies Group, and member of the EAN/MDS-ES Parkinson's Disease Guidelines Task Force and Association of British Neurologists Movement Disorders Advisory Group. She is an Associate Editor for the Journal of Parkinson’s Disease.

Dr Carroll is looking forward to realising the vision of developing a multi-arm, multi-stage platform trial for Parkinson’s.